TW200505466A - Vapor fraction from seeds of glycine max (l.) merr. and composition thereof - Google Patents
Vapor fraction from seeds of glycine max (l.) merr. and composition thereofInfo
- Publication number
- TW200505466A TW200505466A TW092122224A TW92122224A TW200505466A TW 200505466 A TW200505466 A TW 200505466A TW 092122224 A TW092122224 A TW 092122224A TW 92122224 A TW92122224 A TW 92122224A TW 200505466 A TW200505466 A TW 200505466A
- Authority
- TW
- Taiwan
- Prior art keywords
- vapor fraction
- merr
- seeds
- glycine max
- composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q7/00—Preparations for affecting hair growth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction
Abstract
The present invention mainly relates to a vapor fraction from seeds of Glycine max (L.) Merr. prepared by vaporizing a rude extract, and pharmaceutical composition thereof. The present invention also provides the use of the vapor fraction in treating skin injuries, dermatological disorders, stimulating cell regeneration, and stimulating hair growth.
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TW092122224A TWI333420B (en) | 2003-08-11 | 2003-08-11 | Vapor fraction from seeds of glycine max (l.) merr. and composition thereof |
KR1020040063087A KR101284071B1 (en) | 2003-08-11 | 2004-08-11 | Vapor fraction from seeds of glycine max(l.) merr. and composition thereof |
KR1020110040816A KR101220124B1 (en) | 2003-08-11 | 2011-04-29 | Vapor fraction from seeds of glycine max(l.) merr. and composition thereof |
KR1020120056185A KR101252023B1 (en) | 2003-08-11 | 2012-05-25 | Vapor fraction from seeds of glycine max(l.) merr. and composition thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TW092122224A TWI333420B (en) | 2003-08-11 | 2003-08-11 | Vapor fraction from seeds of glycine max (l.) merr. and composition thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
TW200505466A true TW200505466A (en) | 2005-02-16 |
TWI333420B TWI333420B (en) | 2010-11-21 |
Family
ID=37230929
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW092122224A TWI333420B (en) | 2003-08-11 | 2003-08-11 | Vapor fraction from seeds of glycine max (l.) merr. and composition thereof |
Country Status (2)
Country | Link |
---|---|
KR (3) | KR101284071B1 (en) |
TW (1) | TWI333420B (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112022792A (en) * | 2020-09-27 | 2020-12-04 | 黑龙江省中医药科学院 | Preparation method of edible traditional Chinese medicine hair dye with homology of medicine and food |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103948847A (en) * | 2014-05-18 | 2014-07-30 | 黑龙江八一农垦大学 | Traditional Chinese medicine composition for treating non-gonococcal urethritis and preparation method thereof |
US10543243B2 (en) | 2016-06-06 | 2020-01-28 | Charsire Biotechnology Corp. | Soybeam seed extract, method for producing the same and uses thereof |
KR101884221B1 (en) * | 2017-06-02 | 2018-08-01 | 차사이어 바이오테크놀로지 코포레이션 | Soybean seed extract, method for producing the same and uses thereof |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5921364A (en) * | 1982-07-29 | 1984-02-03 | Ajinomoto Co Inc | Preparation of soybean or soybean protein having improved quality |
US6248910B1 (en) * | 1991-12-31 | 2001-06-19 | University Research & Marketing Inc. | Process for extracting oil from oil-bearing naturally occurring organic materials |
JP2000169347A (en) | 1998-12-10 | 2000-06-20 | Junsai Bun | Hair tonic |
KR100370455B1 (en) * | 2000-05-19 | 2003-01-29 | 황상민 | Cosmetic composition for dry skin of atopic dermatitis and recovery of disrupted skin barrier |
KR100361040B1 (en) * | 2000-10-05 | 2002-11-23 | 주식회사 코리아나화장품 | Skin care composition containing stabilized phellodendri radix, macrocarpium dfficinale, rheum coreanum, prunus ansu, angelica gigas, eugenia caryophyllata, imperata cylindrica with niosome |
-
2003
- 2003-08-11 TW TW092122224A patent/TWI333420B/en not_active IP Right Cessation
-
2004
- 2004-08-11 KR KR1020040063087A patent/KR101284071B1/en active IP Right Grant
-
2011
- 2011-04-29 KR KR1020110040816A patent/KR101220124B1/en active IP Right Grant
-
2012
- 2012-05-25 KR KR1020120056185A patent/KR101252023B1/en active IP Right Grant
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112022792A (en) * | 2020-09-27 | 2020-12-04 | 黑龙江省中医药科学院 | Preparation method of edible traditional Chinese medicine hair dye with homology of medicine and food |
CN112022792B (en) * | 2020-09-27 | 2022-12-09 | 黑龙江省中医药科学院 | Preparation method of edible traditional Chinese medicine hair dye with homology of medicine and food |
Also Published As
Publication number | Publication date |
---|---|
KR20110050613A (en) | 2011-05-16 |
KR101252023B1 (en) | 2013-04-08 |
KR20120081046A (en) | 2012-07-18 |
KR20050023196A (en) | 2005-03-09 |
KR101220124B1 (en) | 2013-01-11 |
KR101284071B1 (en) | 2013-07-10 |
TWI333420B (en) | 2010-11-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TW200501983A (en) | Uses of anti-insulin-like growth factor I receptor antibodies | |
WO2005000245A3 (en) | Compositions and methods for increasing telomerase activity | |
TW201129368A (en) | Peptides used in the treatment and/or care of the skin, mucous membranes and/or hair and its use in cosmetic or pharmaceutical compositions | |
WO2004069190A3 (en) | Combination therapy for treating protein deficiency disorders | |
MX337830B (en) | Peptides used in the treatment and/or care of the skin and/or hair and their use in cosmetic or pharmaceutical compositions. | |
WO2005044179A3 (en) | Formulations containing astragalus extracts and uses thereof | |
AU2003301190A1 (en) | Administration of capsaicinoids | |
MXPA05006269A (en) | Use of an extract of decaffeinated coffee beans in the preparation of a composition intended to stimulate the sebaceous function of the skin by oral administration. | |
EP2292264A3 (en) | Methods and compositions for increasing the efficiency of therapeutic antibodies using NK cell potentiating compounds | |
WO2005065269A3 (en) | Compositions and method for decreasing the appearance of skin wrinkles | |
WO2005081742A3 (en) | Testosterone oral dosage formulations and associated methods | |
EP1658853A4 (en) | Remedy for internal administration against cranial nerve diseases containing mesenchymal cells as the active ingredient | |
WO2007024441A3 (en) | Compositions of cells enriched for combinations of various stem and progenitor cell populations, methods of use thereof and methods of private banking thereof | |
WO2010085039A2 (en) | Noggin-derived peptide and use thereof | |
WO2002064088A3 (en) | Pharmaceutical composition for the treatment of alopecia | |
RS20050739A (en) | Pharmaceutical composition comprising an immunosuppressant for use in the treatment of skin diseases | |
PT1414473E (en) | ORAL ADMINISTRATION COMPOSITIONS FOR THE TREATMENT OF CABELUDE LEATHER DISTURBLES | |
TW200724150A (en) | Plant extracts for treating skin disorders and enhancing healing of wounds for diabetics patients | |
EP1556513A4 (en) | Compositions and methods for treating human papillomavirus-mediated disease | |
SG142127A1 (en) | Vapor fraction from seeds of glycine max (l.) merr. and composition thereof | |
TW200505466A (en) | Vapor fraction from seeds of glycine max (l.) merr. and composition thereof | |
DE60310742D1 (en) | EXTRACT WITH ANTITUMORAL AND ANTITOXIC EFFECT | |
WO2005009456A3 (en) | Use of peptidic conjugates for preparing compositions for alopecia preventive and curative treatment | |
MY148508A (en) | Vapor fraction from seeds of glycine max (l.) merr. and compositions thereof | |
EP1546377A4 (en) | Methods and compositions to treat pain and painful disorders using 9949, 14230, 760, 62553, 41897, 47174, 33408, 10002,16209, 314, 636, 27410, 33260, 619,15985, 69112, 2158, 224, 615, 44373, 95431, 22245, 2387, 16658, 55054, 9569 or 13424 molecules |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK4A | Expiration of patent term of an invention patent |